BLUE SKY CASHES IN HATCHTECH INVESTMENT

Written on the 15 September 2015

BLUE SKY CASHES IN HATCHTECH INVESTMENT

BLUE Sky Alternative Investments (ASX:BLA) has marked a milestone in its venture capital division, with the exit of head lice treatment company Hatchtech.

The Melbourne-based pharmaceutical company has entered into a commercial agreement with Dr Reddy's Laboratories in India. The deal is expected to be valued at up to $278 million.

This will be Blue Sky Venture Capital's first exit from its VC2012 portfolio, after investing in Hatchtech in 2013 as part of a $12 million syndicate led by OneVentures.

Along with support from existing backers, the investment allowed the company to complete the final stage of its clinical trial for Xeglyse - a treatment to kill both lice and eggs without the need for a comb.

Blue Sky Venture Capital investment director Dr Elaine Stead (pictured) says the deal is a big win for private capital markets.

"This is a huge deal for Australian venture capital, and for local talent," Stead says.

"It is also a great example of how collaborative the VC industry is in Australia which is a benefit to both investors and the investee company.

"We provided growth capital and, just as importantly, networks and expertise, bringing more smart people and useful networks to the table.

"Without a doubt, we have exceptional and world-class talent in Australia and we are starting to see excellent successes in Australian venture-backed companies that are delivering great results."

Stead says Blue Sky has a policy of taking an active role in all its investee companies to support their expansion.

 


Latest News

CORPORATE TRAVEL MANAGEMENT POSTS STRONG FIRST HALF RESULT

CORPORATE Travel Management (ASX:CTD) battled headwinds including a falling Australian Dollar and an airline price wa...

SLATER AND GORDON FILES CLASS ACTION AGAINST BELLAMY'S

SLATER AND GORDON (ASX:SGH), with funding from IMF Bentham (ASX:IMF), has filed its class action against Bellamy...

BILLABONG'S SALES DEPARTMENT STILL STRUGGLING

SURFWEAR retailer Billabong International (ASX: BBG) hasn't posted any surprises to the ASX.

The Burleigh Head...

EVERYTHING YOU NEED TO KNOW ABOUT THE NATIONAL BROADBAND NETWORK

THE National Broadband Network (NBN) is more than an internet connection, it is an opportunity to transform your b...

Related News

EVERYTHING YOU NEED TO KNOW ABOUT THE NATIONAL BROADBAND NETWORK

THE National Broadband Network (NBN) is more than an internet connection, it is an opportunity to transform your b...

WHY EMPLOYEE-OWNED COMPANIES ARE BEATING ASX200 SHARE PRICES

EMPLOYEE-owned companies command a higher share price than their publicly listed peers, reaping a 17 per cent prem...

RISE OF THE MACHINES HAS WORKERS SWEATING

UP TO 3.8 million Australian workers are fearful their job may soon be terminated by a robot, a new survey has shown....

LESS TALK, MORE SMALL BUSINESS ACTION IN 2017

THE future growth and prosperity of Australian SMEs could be undermined if governments lose sight of the sector...

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter